SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-03-001135
Filing Date
2003-05-02
Accepted
2003-05-02 10:48:33
Documents
3
Group Members
ORBIMED ADVISORS LLCORBIMED CAPITAL LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A (CAPITAL LLC) sc13ga_050103.txt SC 13G/A 8573
3 JOINT FILING AGREEMENT ex1-1_050103.txt EX-1.1 2084
4 STATEMENT OF CONTROL PERSON ex2-1_050103.txt EX-2.1 753
  Complete submission text file 0000947871-03-001135.txt   13702
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Subject) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 0731
Type: SC 13G/A | Act: 34 | File No.: 005-47771 | Film No.: 03678381
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 THIRD AVENUE NEW YORK NY 10017
Business Address 767 THIRD AVENUE NEW YORK NY 10017 2127396400
ORBIMED CAPITAL LLC (Filed by) CIK: 0001157524 (see all company filings)

IRS No.: 134133323 | State of Incorp.: DE | Fiscal Year End: 1231